文献速递肺结节与肺癌

SUMMIT研究中肺癌筛查参与者的症状患病率及其对肺癌风险的影响

Symptom Prevalence and Impact on Lung Cancer Risk in the SUMMIT Study.
PubMed 文献 · Chest · 2026-06-30

BACKGROUND: Lung cancer screening is now widely adopted across health care systems. Screening typically occurs in asymptomatic individuals. Because symptoms of lung cancer overlap with those of chronic conditions, defining asymptomatic screening is challenging.…

要点

  • 肺癌筛查参与者中76%报告至少一种呼吸道或警示症状。
  • 仅6%报告警示症状(咯血或体重减轻)。

核心结论

  • 肺癌筛查参与者中症状常见,有症状者更可能被诊断为肺癌。

研究设计与样本

  • SUMMIT研究为前瞻性观察队列研究,评估低剂量CT肺癌筛查实施。
  • 纳入13035名符合基线低剂量CT扫描条件的参与者。

主要发现

  • 76%(n=9859)报告至少一种症状。
  • 咳嗽见于36%(n=4707),66%报告呼吸困难。
  • 仅6%报告警示症状(咯血或体重减轻)。

关键数值与推荐

  • 警示症状定义为过去一年咯血或3个月内非刻意体重减轻≥5 kg。
  • 非特异症状定义为咳嗽(急性<6周;慢性>6周)和呼吸困难(mMRC评分≥1)。

临床怎么用

  • 筛查中常见症状,不应仅因有症状而排除筛查,但需综合评估症状与肺癌风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lung cancer screening is now widely adopted across health care systems. Screening typically occurs in asymptomatic individuals. Because symptoms of lung cancer overlap with those of chronic conditions, defining asymptomatic screening is challenging. This study outlines the frequency of symptomatic participants in a lung cancer screening trial. RESEARCH QUESTION: How common are respiratory and red flag symptoms in lung cancer screening participants, and how do these symptoms impact screening outcomes? STUDY DESIGN AND METHODS: The SUMMIT study was a prospective observational cohort study to assess the implementation of low-dose CT screening for lung cancer. Baseline clinical assessments collected self-reported symptoms, medical history, demographics, and spirometry. Hemoptysis (in last year) and unintentional weight loss (≥ 5 kg in 3 months) were classified as red flag symptoms, and cough (acute: onset < 6 weeks; chronic: > 6 weeks) and dyspnea (modified Medical Research Council scale score ≥ 1) were classified as nonspecific symptoms. Lung cancer diagnoses within 1 year were ascertained. Multivariable logistic regression was used to assess associations between symptoms and lung cancer. RESULTS: Among 13,035 participants eligible for a baseline LDCT scan, 76% (n = 9,859) reported at least 1 symptom. Cough was present in 36% (n = 4,707), and 66% of participants reported dyspnea. Only 6% of participants reported red flag symptoms, including hemoptysis and weight loss. The presence of any of these symptoms was associated with higher likelihood of lung cancer diagnosis in the year after assessment (OR, 1.45; P = .03, adjusted for other baseline factors). INTERPRETATION: Our results show that symptoms are commonly reported in those undergoing lung cancer screening and those with symptoms are more likely to be diagnosed with lung cancer.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Mullin ML, Creamer AW, Bhamani A, et al. Symptom Prevalence and Impact on Lung Cancer Risk in the SUMMIT Study. Chest. 2026. PMID: 42379289. doi:10.1016/j.chest.2026.03.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。